-
1
-
-
77952777089
-
A current review of the etiology, diagnosis and treatment of pediatric pheochromocytoma and paraganglioma
-
Waguespack SG, Rich T, Grubbs E, et al. A current review of the etiology, diagnosis and treatment of pediatric pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2010;95:2023-2037.
-
(2010)
J Clin Endocrinol Metab.
, vol.95
, pp. 2023-2037
-
-
Waguespack, S.G.1
Rich, T.2
Grubbs, E.3
-
2
-
-
80755127100
-
Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: Significant link to SDHB mutations
-
King KS, Prodanov T, Kantorovich V, et al. Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations. J Clin Oncol. 2011; 29:4137-4142.
-
(2011)
J Clin Oncol.
, vol.29
, pp. 4137-4142
-
-
King, K.S.1
Prodanov, T.2
Kantorovich, V.3
-
3
-
-
79151480949
-
Malignant pheochromocyto-mas and paragangliomas - The importance of a multidisciplinary approach
-
Andersen KF, Altaf R, Krarup-Hansen A, et al. Malignant pheochromocyto-mas and paragangliomas-the importance of a multidisciplinary approach. Cancer Treat Rev. 2011;37:111-119.
-
(2011)
Cancer Treat Rev.
, vol.37
, pp. 111-119
-
-
Andersen, K.F.1
Altaf, R.2
Krarup-Hansen, A.3
-
4
-
-
84895924028
-
(131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: Systematic review and meta-analysis
-
Van Hulsteijn LT, Niemeijer ND, Dekkers OM, et al. (131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis. Clin Endocrinol (Oxf). 2014;80:487-501.
-
(2014)
Clin Endocrinol (Oxf).
, vol.80
, pp. 487-501
-
-
Van Hulsteijn, L.T.1
Niemeijer, N.D.2
Dekkers, O.M.3
-
5
-
-
70249133742
-
131I] metaiodobenzylguanidine therapy for patients with metastatic pheochromo-cytoma and paraganglioma
-
131I] metaiodobenzylguanidine therapy for patients with metastatic pheochromo-cytoma and paraganglioma. J Clin Oncol. 2009;27:4162-4168.
-
(2009)
J Clin Oncol.
, vol.27
, pp. 4162-4168
-
-
Gonias, S.1
Goldsby, R.2
Matthay, K.K.3
-
6
-
-
84868621823
-
Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas
-
Ayala-Ramirez M, Chougnet CN, Habra MA, et al. Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas. J Clin Endocrinol Metab. 2012;97:4040-4050.
-
(2012)
J Clin Endocrinol Metab.
, vol.97
, pp. 4040-4050
-
-
Ayala-Ramirez, M.1
Chougnet, C.N.2
Ma, H.3
-
7
-
-
84874058676
-
Sunitinib for the treatment of metastatic paraganglioma and vasoactive intestinal polypeptide-producing tumor (VIPoma)
-
Bourcier ME, Vinik AI. Sunitinib for the treatment of metastatic paraganglioma and vasoactive intestinal polypeptide-producing tumor (VIPoma). Pancreas. 2013;42:348-352.
-
(2013)
Pancreas.
, vol.42
, pp. 348-352
-
-
Bourcier, M.E.1
Vinik, A.I.2
-
8
-
-
84903533733
-
Sunitinib for refractory malignant pheo-chromocytoma: Two case reports
-
Hata J, Haga N, Ishibashi K, et al. Sunitinib for refractory malignant pheo-chromocytoma: two case reports. Int Urol Nephrol. 2014;46:1309-1312.
-
(2014)
Int Urol Nephrol.
, vol.46
, pp. 1309-1312
-
-
Hata, J.1
Haga, N.2
Ishibashi, K.3
-
9
-
-
58149385799
-
Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma
-
Joshua AM, Ezzat S, Asa SL, et al. Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma. J Clin Endocrinol Metab. 2009;94:5-9.
-
(2009)
J Clin Endocrinol Metab.
, vol.94
, pp. 5-9
-
-
Joshua, A.M.1
Ezzat, S.2
Asa, S.L.3
-
12
-
-
84947025820
-
177Lu-DOTA0Tyr3]octreotate in combination with RAD001 treatment: Further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model
-
177Lu-DOTA0Tyr3]octreotate in combination with RAD001 treatment: further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model. EJNMMI Res. 2014;4:21.
-
(2014)
EJNMMI Res.
, vol.4
, pp. 21
-
-
Bison, S.M.1
Pool, S.E.2
Koelewijn, S.J.3
|